Skip to main content

Synonyms

Inhalational anthrax; Respiratory anthrax; Anthrax pneumonia; Wool-sorter’s disease; Blackbane (medieval term)

Definition and Characteristics

Pulmonary anthrax is an infectious disease caused by the inhalation of bacillus anthracis spores. B. anthracis is an aerobic, Gram-positive, spore-forming, non-motile bacillus species [1]. Following infection, the bacilli proliferate, producing their main virulence factors: a capsule and two toxins (edema toxin [ET] and lethal toxin [LT]). Anthrax meningitis is a common complication of pulmonary anthrax. The 50% lethal dose in humans has been estimated at 40,000 spores.

Spore inhalation is followed by a period of incubation ranging from 1 to 10 days (range of 4–6 days for the US outbreak in 2001), but infection may occur up to 43 days after spore inhalation (Sverdlosk outbreak, 1979). The clinical presentation of anthrax comprises two stages. In the first stage, patients report atypical flu-like signs including fever, chills, cough,...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,099.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, McDade J, Osterholm MT, Parker G, Perl TM, Russell PK, Tonat K (2002) JAMA 287:2236–2252

    PubMed  Google Scholar 

  2. Holty JE, Bravata DM, Liu H, Olshen RA, McDonald KM, Owens, DK (2006) Ann Intern Med 144:270–280

    PubMed  Google Scholar 

  3. Read TD, Peterson SN, Tourasse N, Baillie LW, Paulsen IT, Nelson KE, Tettelin H, Fouts DE, Eisen JA, Gill SR, Holtzapple EK, Okstad OA, Helgason E, Rilstone J, Wu M, Kolonay JF, Beanan MJ, Dodson RJ, Brinkac LM, Gwinn M, DeBoy RT, Madpu R, Daugherty SC, Durkin AS, Haft DH, Nelson WC, Peterson JD, Pop M, Khouri HM, Radune D, Benton JL, Mahamoud Y, Jiang L, Hance IR, Weidman JF, Berry KJ, Plaut RD, Wolf AM, Watkins KL, Nierman WC, Hazen A, Cline R, Redmond C, Thwaite JE, White O, Salzberg SL, Thomason B, Friedlander AM, Koehler TM, Hanna PC, Kolsto AB, Fraser CM (2003) Nature 423:81–86

    PubMed  CAS  Google Scholar 

  4. Tournier JN, Quesnel-Hellmann A, Cleret A, Vidal DR (2007) Cell Microbiol 9:555–565

    PubMed  CAS  Google Scholar 

  5. Kyriacou DN, Stein AC, Yarnold PR, Courtney DM, Nelson RR, Noskin GA, Handler JA, Frerichs RR (2004) Lancet 364:449–452

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag GmbH Berlin Heidelberg

About this entry

Cite this entry

Tournier, JN. (2009). Pulmonary Anthrax. In: Lang, F. (eds) Encyclopedia of Molecular Mechanisms of Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29676-8_3234

Download citation

Publish with us

Policies and ethics